Cystic Fibrosis: Renewed Hopes Through ResearchLiving healthy is all one wants, but the genetics behind creation of every human is different. As a curse or human agony, some are born with congenital defects in their menu of the genome. Just one has to live with that! The complexity of cystic fibrosis condition, which is rather a slow-killer, affects various organ systems of the human body complicating further with secondary infections. That's what makes the disease so puzzling for which scientists around the world are trying to understand better and to find a cure. Though they narrowed down to a single target gene, the tentacles of the disease reach many unknown corners of the human body. Decades of scientific research in the field of chronic illnesses like this one surely increased the level of life expectancy. This book is the compilation of interesting chapters contributed by eminent interdisciplinary scientists around the world trying to make the life of cystic fibrosis patients better. |
Avis des internautes - Rédiger un commentaire
Aucun commentaire n'a été trouvé aux emplacements habituels.
Table des matières
The Prognosis of Cystic Fibrosis | 3 |
Radiological Features of Cystic Fibrosis | 31 |
Past Observations | 51 |
Cystic Fibrosis and Infertility | 67 |
Genotype Phenotype Relationship | 91 |
Biochemical and Molecular Genetic Testing Used | 123 |
Pseudomonas aeruginosa Biofilm Formation | 153 |
Outcome and Prevention of Pseudomonas aeruginosa | 181 |
Channel Replacement Therapy for Cystic Fibrosis | 291 |
Fine Tuning of CFTR Traffic | 359 |
CFTR Gene Transfer and Tracking | 379 |
VIP as a Corrector | 397 |
Pharmacological Potential | 413 |
Pharmacological Modulators of Sphingolipid Metabolism | 439 |
The Importance of Adherence | 455 |
Improving the Likelihood of Success in Trials | 473 |
Infection by Non Tuberculous | 207 |
Diversity | 225 |
Viral Respiratory Tract Infections in Cystic Fibrosis | 253 |
Immune Dysfunction in Cystic Fibrosis | 273 |
The Physiotherapists Use of Exercise | 519 |
Exercise Performance | 541 |
Expressions et termes fréquents
activity adherence aeruginosa infection airway epithelial cells alleles analysis antibiotic antimicrobial associated aureus bacteria biofilm Biol CBAVD CF airways CF lung CF patients CFTR gene CFTR mutations channel chloride chronic clearance Clin clinical Cyst Fibros cystic fibrosis patients cystic fibrosis transmembrane cytokines detection diagnosis domain drug effect epithelial cells epithelium exacerbations exercise expression factors FEV1 fibrosis transmembrane conductance genetic genotype human identified immune increased inflammation inflammatory influenza inhaled inhibition inhibitors interactions isolated ISSN levels lung disease M2GlyR mice Microbiol Microbiology miglustat molecular molecule mucus mutations mycobacteria nasal neutrophils NHERF1 pancreatic pathogens patients with CF patients with cystic PDE5 inhibitors Pediatr Pulmonol peptide phenotype phosphodiesterase Physiol potential protein Pseudomonas aeruginosa pulmonary receptor Respir Crit role screening secretion sequence sildenafil specific sputum Staphylococcus aureus sweat test tadalafil target therapeutic therapy tobramycin transmembrane conductance regulator treatment vardenafil vectors viral virulence virus